Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHays Regulatory News (HAS)

Share Price Information for Hays (HAS)

Share Price is delayed by 15 minutes
Get Live Data
35.18    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.12 (0.341%)
Market Cap: £558.05m
HAS Live PriceLast checked at - London Stock Exchange

Intraday Hays Share Chart

Holding(s) in Company

18 Aug 2022 12:08

RNS Number : 5047W
Hays PLC
18 August 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0004161021

Issuer Name

HAYS PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

SILCHESTER INTERNATIONAL INVESTORS LLP

City of registered office (if applicable)

London

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Name

City of registered office

Country of registered office

Silchester International Investors International Value Equity Trust

New York

USA

5. Date on which the threshold was crossed or reached

17-Aug-2022

6. Date on which Issuer notified

18-Aug-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

12.030000

0.000000

12.030000

197045355

Position of previous notification (if applicable)

11.027000

0.000000

11.027000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB0004161021

0

197045355

0.000000

12.030000

Sub Total 8.A

197045355

12.030000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

Silchester International Investors LLP ("Silchester") acts as investment manager for certain commingled funds (our "Clients"). One of these Clients is listed in Box 4 - Silchester International Investors International Value Equity Trust. No other client holds more than 5% of voting rights. In acting for our Clients, Silchester is given full discretion over their investments and is empowered to vote on their behalf. However, we do not act as our Clients' custodian and therefore shares are not held in our name but in the name of each Client's custodian bank. The change in Silchester's holdings was due to a series of transactions over a series of different trading days.

12. Date of Completion

18-Aug-2022

13. Place Of Completion

London, UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEAFPPFEXAEFA
Date   Source Headline
17th Jun 20267:00 amRNSHays announces reshaping of country portfolio
15th Jun 202611:30 amRNSTransaction in Own Shares
10th Jun 20261:48 pmRNSDirector/PDMR Shareholding
8th Jun 202611:10 amRNSShare Buyback Programme
8th Jun 202611:05 amRNSTransaction in Own Shares
4th Jun 20262:18 pmRNSDirector/PDMR Shareholding
1st Jun 202611:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSShare buyback programme
27th May 20269:14 amRNSHolding(s) in Company
19th May 20265:00 pmRNSDirector/PDMR Shareholding
18th May 20267:05 amRNSDirector/PDMR Shareholding
18th May 20267:00 amRNSCEO Appointment
1st May 202610:00 amRNSTotal Voting Rights
29th Apr 20264:06 pmRNSDirector/PDMR Shareholding
28th Apr 20269:59 amRNSDirector/PDMR Shareholding
22nd Apr 20262:09 pmRNSHolding(s) in Company
22nd Apr 20262:06 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSThird Quarter Trading Statement
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
1st Apr 202611:00 amRNSTotal Voting Rights
27th Mar 20265:00 pmRNSHolding(s) in Company
27th Mar 20264:11 pmRNSDirector/PDMR Shareholding
25th Mar 202610:05 amRNSDirector/PDMR Shareholding
4th Mar 20261:24 pmRNSDirector/PDMR Shareholding
3rd Mar 20264:08 pmRNSDirector/PDMR Shareholding
2nd Mar 20263:00 pmRNSDirector/PDMR Shareholding
2nd Mar 202611:00 amRNSTotal Voting Rights
27th Feb 20264:15 pmRNSHolding(s) in Company
27th Feb 20267:01 amRNSCEO departure and succession plan
27th Feb 20267:00 amRNSHalf-Year Report
2nd Feb 202611:00 amRNSTotal Voting Rights
14th Jan 20267:00 amRNSSecond Quarter Trading Statement
5th Jan 20267:00 amRNSCEO update
2nd Jan 202610:00 amRNSTotal Voting Rights
1st Dec 202511:00 amRNSTotal Voting Rights
21st Nov 20253:10 pmRNSDirector/PDMR Shareholding
19th Nov 20252:33 pmRNSResult of AGM
11th Nov 202512:00 pmRNSDirector/PDMR Shareholding
10th Nov 20257:00 amRNSCEO Medical Leave
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 202510:00 amRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.